Jun. 19 at 10:26 PM
$GLTO all the excitement over GALT is about to trigger an avalanche over here! After listening to GALTs KOL I think belapectin is approvable. FOMO traders will be looking for other galectin biology plays and GLTO is it. Selvigaltin is further away in liver disease but closer for cancer. Traders will go nuts when they realize GLTO float is only 1M shares and MC just
$4M. The fact that selvigaltin is also oral makes this even more appealing. GALT is developing an oral version of belapectin but is still pre clinical and will have to run additional trials including P3 for the oral version. It’s about to get exciting over here and it’s about time!